Blood cells perform a host of critical homeostatic and developmental functions. These include the phagocytosis of pathogens, cellular debris and other materials, and the secretion of cytokines and antimicrobial peptides to aid in immunity. In insects such as the fruit fly *Drosophila melanogaster*, these functions are performed by cells called hemocytes that circulate in the hemolymph both throughout development and in the adult. *Drosophila* have three types of mature hemocytes: plasmatocytes, crystal cells and lamellocytes. Plasmatocytes are phagocytic macrophage-like cells that make up \>90% of the total hemocyte population, and function in pathogen elimination and tissue remodelling ([@bib16], [@bib34]). Crystal cells facilitate wound healing and pathogen neutralization via melanisation, and comprise \<5% of hemocytes ([@bib22], [@bib16], [@bib25]). Lamellocytes are large, highly specialized hemocytes that function to encapsulate wasp eggs, however they typically only appear upon wasp parasitisation ([@bib24]).

Hemocytes do not proliferate in adult flies ([@bib27]). Instead, all hemocytes in the adult fly derive from two populations of undifferentiated cells, called prohemocytes, that are specified at different stages of development ([@bib13]). The first prohemocyte population originates in the procephalic mesoderm of the embryo ([@bib34]). Here, prohemocytes proliferate and differentiate into plasmatocytes and crystal cells, which then migrate throughout the embryo ([@bib34]). Embryonic plasmatocytes, but not crystal cells, persist into the larval stages and undergo a phase of proliferative expansion as the larva grows ([@bib17], [@bib16], [@bib13]). During this stage, these plasmatocytes can either circulate within the hemolymph or reside sessile in hematopoietic pockets at the larval body wall, where they are known to proliferate at an increased rate ([@bib16], [@bib20]). Crystal cells are also produced from these plasmatocytes in the larva via transdifferentiation ([@bib18]). The second population of prohemocytes is found in the larval lymph gland. Here, prohemocytes proliferate and differentiate into both crystal cells and plasmatocytes, which are then released into circulation during metamorphosis ([@bib13], [@bib10]).

Hemocytes are necessary to maximize an individual's ability to survive upon infection. For example, the ablation of post-embryonic hemocytes increases the proportion of flies that die upon infection by several different pathogens ([@bib4], [@bib6]). While much attention has been given to the functions of hemocytes in immunity, we know relatively little about the factors and mechanisms that control hemocyte population size. There are several signaling pathways are currently known to control *Drosophila* hemocyte number. These include the Platelet Derived Growth Factor/Vascular Endothelial Growth Factor Receptor (Pvr) pathway, which acts to maintain hemocyte survival during embryogenesis ([@bib3]), and the Activin-β pathway, which is proposed to coordinate larval hemocyte proliferation both by facilitating the accumulation of sessile hemocytes in hematopoietic pockets and by acting as a proliferative cue ([@bib19]). Given the complexity and size of the cellular immune system, and its importance to individual fitness, it is likely that there are many factors and pathways still to be identified that serve to control hemocyte numbers.

Recently, [*torso*](https://flybase.org/reports/FBgn0003867)*-like* null (*tsl*^*Δ*^*/ tsl^Δ^*) mutant larvae were shown to have a reduced number of circulating plasmatocytes and crystal cells, implicating Tsl as a novel regulator of hemocyte number ([@bib8]). Tsl is a member of the Membrane Attack Complex/Perforin-like (MACPF) protein family, and has been shown to control a variety of developmental processes by modulating the activity of several different cell signaling pathways. These include terminal patterning in the early embryo via the Torso receptor ([@bib32]), embryonic morphogenesis via Fog signaling ([@bib15]), and both larval growth and developmental timing via Insulin-like signaling ([@bib14], [@bib11]). Due to the latter roles, [*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) mutants have a reduced body size and a developmental delay. Here, we show that the reduced hemocyte number observed in *tsl* mutant animals is the result of the reduction in body size, and we further find that the same phenotype occurs upon modulating insulin-like signaling, both systemically and directly in hemocytes. Together, these data suggest that [*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) acts with the insulin-like signaling pathway and that these contribute to coordinating hemocyte number with body size in *Drosophila* larvae.

Materials and Methods {#s1}
=====================

Drosophila stocks and maintenance {#s2}
---------------------------------

The following stocks were from the Bloomington *Drosophila* Stock Centre: *w*^1118^ (BL3605), *hml-GAL4,UAS-GFP* (BL6397), *hmlΔ-GAL4,UAS-GFP* (BL30142), *UAS-RedStinger* (BL8546), *Df(3R)*ca*ki*^X-313^ (BL6784; called *tsl*^*caki*^ here), *chico*^*1*^ (BL10738), *Df(2L)BSC143* (BL9503; called *chico*^*df*^ here), UAS-InR^CA^ (BL8263) and UAS-InR^DN^ (BL8251). *srpHemo-GAL4* and *hmlΔ-dsRed* were kind gifts from Katja Brückner ([@bib3], [@bib20]). *tsl*^Δ^ is as previously described ([@bib14]). *chico*^*1*^ and *chico*^*df*^ were maintained over green (GFP) balancers and experiments conducted on transheterozygous *chico*^*1*^/*chico*^*df*^ mutants as both *chico*^*1*^ and *chico*^*df*^ homozygotes had a low rate of survival to wandering stage. *tsl*^Δ^, *tsl*^*caki*^ and *hmlΔ-GAL4,UAS-GFP* were maintained over TM6B. Flies were raised and maintained on standard sucrose, yeast and semolina fly media except where otherwise stated. For all experiments flies were maintained at 25° except for the InR transgene expression experiment, which was performed at 29°.

Embryonic hemocyte imaging and quantification {#s3}
---------------------------------------------

Embryos laid by females from a cross between *srpHemo-Gal4*, which expresses in embryonic hemocytes ([@bib3]), and *UAS-RedStinger* lines were collected on apple juice agar supplemented with yeast paste overnight. Embryos were dechorionated in 50% vol/vol bleach before fixation in phosphate buffered saline (PBS) with 4% paraformaldehyde and an equal volume of heptane for 30 min. Vitelline membranes were removed by the addition of methanol before rehydration in PBS with 0.1% Triton X-100. Embryos were mounted in Vectashield and imaged at 20x magnification on an Olympus CV1000 confocal microscope. Maximum projection images were generated from 12 z-slices per embryo (stage 16) with at least 17 embryos sampled for each genotype. Hemocytes were counted using the 'Image-based Tool for Counting Nuclei (ITCN)' plugin for ImageJ ([@bib29]).

Embryonic hemocyte migration patterns were recorded by live-imaging embryos of the genotype described above following a two-hour egg collection. Embryos then developed for four hours before their dechorionation and mounting in an 8-well slide (Ibidi) containing PBS. Embryos were imaged for 9 hr (from approximately stage 10 to 16) at 20x magnification using a confocal microscope (CV1000). Twenty z-slices with a z-step distance \<3.5μm were acquired at 5-minute intervals for each embryo and at least 15 embryos were imaged per genotype.

Larval weighing and hemocyte quantification {#s4}
-------------------------------------------

Embryos were laid on apple juice agar supplemented with yeast paste for 24 hr. 0-24 hr old larvae were collected, selecting against green balancers where required, and reared on standard fly media (or a 25% dilution of standard fly media where indicated) in non-crowded, density-controlled conditions. Third instar wandering stage larvae were used for larval hemocyte analyses except where stated otherwise, selecting against TM6B larvae where required. To weigh larvae, individuals were first washed in PBS, checked to ensure that all debris was removed, blotted dry and weighed on an ultra-microbalance (XP2U, Mettler Toledo) immediately prior to bleeding.

Fluorescent circulating and sessile hemocytes were quantified following their extraction from larvae containing either *hml-GAL4, UAS-GFP*; *hmlΔ-GAL4,UAS-GFP*; or *hmlΔ-dsRed* transgenes, which all express in larval hemocytes ([@bib9], [@bib30], [@bib20]). To extract circulating hemocytes, larvae were washed once in PBS, transferred individually to an 8-well slide (Ibidi) containing PBS, and then bled for at least two minutes through a hole torn in their dorsal-posterior cuticle. Sessile hemocytes were then removed by scraping the remaining hemocytes from the carcass into a new well containing PBS, being careful to avoid disruption to lymph glands, as previously described ([@bib21]). Hemocytes were resuspended by pipetting to minimize clumping, allowed to settle for 10 min, then the entire well was imaged using a Leica AF6000 LX for the nutrient deprivation and InR transgene expression experiments, or an Olympus CV1000 for all other experiments. The number of fluorescent cells per well was quantified using ImageJ as previously described ([@bib21]). The total number of hemocytes per larva was calculated as the sum of the circulating and sessile hemocytes. Differences between means were assessed using the non-parametric Mann-Whitney test (Graphpad Prism 8). Regression analyses were performed following log transformation to ensure linearity across the data range (RStudio). Graphs of the untransformed data used for regression analyses are supplied for reference (Fig. S1-S2).

Data availability {#s5}
-----------------

Data and reagents are available upon request. Accompanying this manuscript are two data supplements: Figures S1-S3 and Tables S1-S4. Supplemental material available at figshare: <https://doi.org/10.25387/g3.12162750>.

Results {#s6}
=======

We previously reported that *tsl*^*Δ*^*/tsl^Δ^* mutant adults have compromised immunity and a reduced ability to clear pathogens, likely caused by the markedly reduced number of circulating larval plasmatocytes and crystal cells found in these animals ([@bib8]). Since circulating larval hemocytes originate from the embryonic rather than lymph gland hemocyte lineage, Tsl must control circulating hemocyte number by acting either during the embryonic or larval stages of hematopoiesis. To distinguish between these possibilities, we first measured the hemocyte number in *tsl*^*Δ*^*/tsl^Δ^* homozygous mutant embryos while marking their hemocytes using *srpHemo-GAL4 \> UAS-RedStinger*. We found no difference in hemocyte number between *tsl*^*Δ*^*/tsl^Δ^* and control *tsl*^*Δ*^/+ embryos ([Figure 1A](#fig1){ref-type="fig"}, *P* = 0.821). We also used live-imaging to track hemocyte migration patterns and found no migration defects in *tsl*^*Δ*^*/tsl^Δ^* embryos compared to control *tsl*^*Δ*^/+ embryos ([Figure 1B](#fig1){ref-type="fig"}). These data suggest that Tsl does not influence embryonic hemocyte development, and therefore may act during larval hematopoiesis.

![Tsl influences larval hemocyte numbers. (A) Hemocyte numbers in stage 16 *tsl*^*Δ*^*/ tsl^Δ^* and *tsl*^*Δ*^/+ embryos (*srpHemo-GAL4 \> UAS-RedStinger*). No difference in hemocyte number was observed. (*P* = 0.821, n ≥ 17). (B) Stills from live-imaging of stage 12-15 *tsl*^*Δ*^*/ tsl^Δ^* and *tsl*^*Δ*^/+ embryos. Arrows indicate the movement of hemocytes. No difference in migration pattern was observed between *tsl*^*Δ*^*/ tsl^Δ^* and *tsl*^*Δ*^/+ control embryos. (C) Circulating hemocyte counts from *tsl*^*Δ*^*/tsl^Δ^* and *tsl*^*Δ*^/+ larvae at regular time points after transitioning to the third larval stage (L3) of development (n ≥ 4). NS, not significant, \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, Mann-Whitney test. Data points are individual animals with means ± 1 SE indicated.](2213f1){#fig1}

To test this, we next counted circulating hemocytes in *tsl*^*Δ*^*/tsl^Δ^* larvae throughout the third instar larval stage (using *hemolectin (hml)-GAL4 \> UAS-GFP*). A significant reduction in circulating hemocyte numbers was apparent in *tsl*^*Δ*^*/tsl^Δ^* larvae upon moulting to the third instar stage compared to *tsl*^*Δ*^/+ controls ([Figure 1C](#fig1){ref-type="fig"}, *P* \< 0.001). This difference became more pronounced in the late third instar stage ([Figure 1C](#fig1){ref-type="fig"}, 72h, *P* = 0.001), suggesting that Tsl may be continually required for the expansion of the hemocyte population throughout late larval development.

Recent work has shown that the larval hemocytes that reside in sessile patches proliferate more rapidly than those in circulation, and an inability of hemocytes to associate in sessile patches can disrupt their relative numbers and subsequently overall larval hemocyte number ([@bib20], [@bib19]). This prompted us to explore whether [*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) influences the sessile hemocyte population (*hmlΔ-dsRed*). For this and all subsequent hemocyte quantification experiments, hemocytes were quantified in wandering larvae to negate any effects that developmental delays may have on hemocyte number. We found that wandering *tsl*^*Δ*^*/tsl^Δ^* larvae indeed have a greatly reduced number of sessile hemocytes compared to *tsl*^*Δ*^/+ controls ([Figure 2A](#fig2){ref-type="fig"}, *P* = 0.003). We also asked if Tsl affects the accumulation of hemocytes in sessile patches by determining the proportion of hemocytes in circulation relative to the total number. This showed that the proportion of hemocytes in circulation relative to the total number does not differ between *tsl*^*Δ*^*/tsl^Δ^* and *tsl*^*Δ*^/+ larvae at wandering stage ([Figure 2B](#fig2){ref-type="fig"}, *P* = 0.573). To confirm that these observations are due to the loss of [*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) rather than a genetic background effect in *tsl*^*Δ*^*/tsl^Δ^* mutants, these experiments were repeated using a transheterozygous [*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) allele combination (*tsl*^*Δ*^/*tsl*^*caki*^; *hmlΔ-dsRed*). Like *tsl*^*Δ*^*/tsl^Δ^* mutants, *tsl*^*Δ*^/*tsl*^*caki*^ mutants also exhibited fewer sessile hemocytes ([Figure 2C](#fig2){ref-type="fig"}, *P* \< 0.001) and did not have an altered proportion of circulating hemocytes relative to the total number of hemocytes compared to both heterozygous controls ([Figure 2D](#fig2){ref-type="fig"}, *P* = 0.915 for *tsl*^*Δ*^/+ and *P* = 0.451 for *tsl*^*caki*^/+). Together, these results indicate that while [*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) is required in larvae for the control of circulating and sessile hemocyte numbers, it is unlikely to do so by influencing hemocyte adhesion in sessile patches.

![Tsl is required for both sessile and circulating larval hemocyte populations. (A) Quantification of sessile hemocyte numbers (*hmlΔ-dsRed*) in wandering *tsl*^*Δ*^*/tsl^Δ^* and *tsl*^*Δ*^/+ larvae. *tsl*^*Δ*^*/tsl^Δ^* larvae have significantly fewer sessile hemocytes than *tsl*^*Δ*^/+ controls (*P* = 0.003). (B) No significant difference in the proportion of hemocytes in circulation was observed between wandering *tsl*^*Δ*^*/tsl^Δ^* mutant and *tsl*^*Δ*^/+ control larvae (*P* = 0.573). (C) Quantification of sessile hemocyte numbers (*hmlΔ-dsRed*) in wandering *tsl*^*Δ*^/+, *tsl*^*caki*^/+ and *tsl*^*Δ*^/*tsl*^*caki*^ larvae. *tsl*^*caki*^*/tsl^Δ^* transheterozygote larvae have significantly fewer sessile hemocytes than both heterozygous controls (*P* \< 0.001). (D) No significant difference in the proportion of hemocytes in circulation was observed between wandering *tsl*^*Δ*^/*tsl*^*caki*^ larvae and either *tsl*^*Δ*^/+ (*P* = 0.915) or *tsl*^*caki*^/+ controls (*P* = 0.451). NS, not significant, \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, Mann-Whitney test. Data points are individual larvae with the mean ± 1 SE indicated (n ≥ 6).](2213f2){#fig2}

[*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) mutant animals have previously been reported to have a reduced growth rate and body size due to a disruption in the insulin-like signaling pathway ([@bib11], [@bib14]). Therefore, we questioned whether this could be contributing to the larval hemocyte number deficit. Since both weight and hemocyte number are quantitative traits we tested this by weighing individual *tsl*^*Δ*^/+ and *tsl*^*Δ*^*/tsl^Δ^* larvae (as a proxy for body size and therefore growth) and counting their total hemocyte number (*i.e.*, circulating and sessile, *hmlΔ-dsRed*) at the wandering stage. We found that hemocyte number increases linearly with body size ([Figure 3A](#fig3){ref-type="fig"}, log(weight) effect *P* = 0.004, Table S1) and this relationship is the same for both genotypes ([Figure 3A](#fig3){ref-type="fig"}; Table S1, weight\*genotype effect *P* = 0.594). However, for any given weight, *tsl*^*Δ*^*/tsl^Δ^* larvae have fewer hemocytes when compared to *tsl*^*Δ*^/+ controls ([Figure 3A](#fig3){ref-type="fig"}; Table S1, genotype effect *P* \< 0.001). To determine if this weight-independent effect was due specifically to loss of [*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) or other elements in the genetic background, we repeated the test using *tsl*^*Δ*^/*tsl*^*caki*^ larvae (*hmlΔ-dsRed*). This confirmed that these larvae also have a reduction in total hemocyte number compared to both heterozygote controls ([Figure 3B](#fig3){ref-type="fig"}, *P* \< 0.001), and the effect of weight on hemocyte number was again observed ([Figure 3C](#fig3){ref-type="fig"}; Table S2, log(weight) effect *P* = 0.034). However, for this genotype we did not detect a weight-independent effect of [*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) on hemocyte number ([Figure 3C](#fig3){ref-type="fig"}; Table S2, genotype effect *P* = 0.007 and Tukey post-hoc *P* \< 0.05 for all genotypic combinations). This suggests that there may be other genetic changes present in the *tsl*^*Δ*^*/tsl^Δ^* background that influence hemocyte number independently of an effect on body size. Thus, overall these data strongly suggest that [*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) influences hemocyte number via its effect on larval body size.

![The reduced hemocyte number in [*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) mutants is the result of larval growth impairment. (A) Quantification of weight and total hemocyte number (*hmlΔ-dsRed*) in individual wandering *tsl*^*Δ*^*/tsl^Δ^* and *tsl*^*Δ*^/+ larvae. While a relationship exists between total hemocyte number and weight, for any given weight *tsl*^*Δ*^*/tsl^Δ^* mutant larvae have fewer hemocytes than their heterozygous counterparts. (B) Analysis of wandering *tsl*^*Δ*^/+, *tsl*^*caki*^/+ and *tsl*^*Δ*^/*tsl*^*caki*^ larvae (*hmlΔ-dsRed*) reveals that wandering *tsl*^*Δ*^/*tsl*^*caki*^ larvae have significantly fewer hemocytes than both heterozygous controls (*P* \< 0.001, n ≥ 14). (C) Data from (B) incorporating larval weights shows that *tsl*^*Δ*^/*tsl*^*caki*^ larvae have fewer hemocytes than their heterozygous counterparts because they weigh less. For (A) and (C) regression lines that cannot be represented by the same line of best fit are indicated by different lowercase letters. NS, not significant, \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, Mann-Whitney test. Data points are individual larvae with the means ± 1 SE indicated.](2213f3){#fig3}

Since [*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) has been shown to mediate growth and final body size via the insulin-like signaling pathway, we next investigated whether insulin-like signaling also impacts the larval hemocyte population. For this we quantified weight and hemocyte numbers in wandering larvae that were mutant for [*chico*](https://identifiers.org/bioentitylink/FB:FBgn0024248?doi=10.1534/g3.120.401313), which encodes an adaptor protein required for transduction of the InR signal ([@bib2]). Consistent with previous reports for [*chico*](https://identifiers.org/bioentitylink/FB:FBgn0024248?doi=10.1534/g3.120.401313) mutant animals ([@bib2]), we found that transheterozygous [*chico*](https://identifiers.org/bioentitylink/FB:FBgn0024248?doi=10.1534/g3.120.401313) mutants (*chico*^*1*^*/chico^df^*) are significantly smaller than both controls ([Figure 4A](#fig4){ref-type="fig"}; *P* \< 0.001). In addition, *chico*^*1*^*/chico^df^* larvae exhibited a significant reduction in hemocyte number compared to both heterozygote controls (*hmlΔ-GAL4 \> UAS-GFP*, [Figure 4B](#fig4){ref-type="fig"}; *P* \< 0.001). This effect is explained by their reduced size, with no weight-independent effects observed ([Figure 4C](#fig4){ref-type="fig"}; Table S3, log(weight) effect *P* \< 0.001, genotype effect *P* = 0.322). Thus, both loss of [*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) and reduced insulin-like signaling impacts the size of the hemocyte population via their effect on whole animal body size.

![Insulin-like signaling in hemocytes links nutrient-dependent larval growth to hemocyte number. (A) *chico*^*1*^*/chico^df^* larvae are significantly smaller than both heterozygous controls (*P* \< 0.001, n ≥ 10) at the wandering stage. (B) Wandering *chico*^*1*^*/chico^df^* larvae have significant fewer hemocytes than both heterozygous controls (*hmlΔ-GAL4 \> UAS-GFP*, *P* \< 0.001, n ≥ 10). (C) Data in (B) incorporating larval weights shows that wandering *chico*^*1*^*/chico^df^* larvae have fewer hemocytes than their heterozygous counterparts because of their reduced weight. (D) Larvae raised on a diluted diet (25%) were significantly smaller than larvae raised on the standard 100% diet (*P* \< 0.001, n ≥ 16) at the wandering stage. (E) Wandering larvae raised on a 25% diet had significantly fewer hemocytes than fully fed controls (*hmlΔ-dsRed*, *P* \< 0.001). (F) Combining data in (D, E) shows that wandering larvae raised on the 25% diet have fewer hemocytes than those on the 100% diet because of their reduced weight. (G) Quantification of total hemocyte number (*hml-GAL4 \> UAS-GFP*) in wandering stage larvae expressing either *InR*^*DN*^ or *InR*^*CA*^ in hemocytes throughout larval development. Expression of *InR*^*DN*^ resulted in a reduction in total hemocyte number (*P* = 0.030), while expression of *InR*^*CA*^ resulted in an increase (*P* = 0.039, n ≥ 8). For (B, E) regression lines that cannot be represented by the same line of best fit are indicated by different lowercase letters. NS, not significant, \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, Mann-Whitney test. Data points are individual larvae with means ± 1 SE indicated.](2213f4){#fig4}

Nutrient deprivation also causes a reduction in larval weight and body size due to altered levels of insulin-like signaling ([@bib12]). Therefore, as an alternative means of inducing insulin-dependent growth impairment, we next quantified hemocytes bled from wildtype wandering larvae (*hmlΔ-dsRed*) fed on a nutrient deprived diet compared to a normal diet. As expected, we found that reducing the concentration of our standard diet to 25% of normal nutrient levels significantly reduced larval weights ([Figure 4D](#fig4){ref-type="fig"}; *P* \< 0.001). We observed corresponding significant reductions in hemocyte number in these larvae ([Figure 4E](#fig4){ref-type="fig"}; *P* \< 0.001). The variation in hemocyte number was largely attributed to weight regardless of the diet on which the larva was raised ([Figure 4F](#fig4){ref-type="fig"}; Table S4, log(weight) effect *P* \< 0.001, diet effect *P* = 0.663). Together, these data further support the idea that insulin signaling links the size of the hemocyte population to overall larval growth.

We next asked if insulin signaling was regulating hemocyte population size via a cell autonomous role in the hemocytes themselves, or indirectly via roles in other tissues. To test this, we expressed transgenes carrying dominant negative and constitutively active forms of [*InR*](https://identifiers.org/bioentitylink/FB:FBgn0283499?doi=10.1534/g3.120.401313) (*InR*^*DN*^ and *InR*^*CA*^, respectively) specifically in larval hemocytes using *hml-GAL4*. Reducing insulin-like signaling by expression of *InR*^*DN*^ resulted in a significant reduction in total larval hemocyte number (driven by *hml-GAL4 \> UAS-GFP*, [Figure 4G](#fig4){ref-type="fig"}; *P* = 0.030), and this was not due to any indirect effects of hemocyte driven *InR*^*DN*^ expression on body size (Fig. S3, *P* = 0.739). Overactivation of insulin-like signaling via expression of *InR*^*CA*^ had the opposite effect and increased hemocyte numbers approximately twofold ([Figure 4G](#fig4){ref-type="fig"}; *P* = 0.039). These data strongly suggest that, during the larval stages, insulin-like signaling in hemocytes is important for the regulation of their overall hemocyte numbers.

Discussion {#s7}
==========

Here we provide the first evidence for a strong relationship between body size and hemocyte number in *Drosophila* larvae. First, this highlights the importance of accounting for differences in larval weight when using whole animal mutant lines to identify novel regulators of larval hemocyte number. We have found that up to 80% of the variation observed in larval hemocyte number within genotypes is due solely to variation in larval weight, despite controlling for factors that influence body size variation such as larval culture density ([@bib28]). We therefore recommend using an approach that accounts for body size variation to enable more subtle changes to larval hemocyte number to be detected.

Second, we find that the relationship between body size and hemocyte number is linear, suggesting that it is important for larvae to keep hemocyte concentration (hemocytes per unit weight) constant no matter the body weight attained. This is consistent with what is observed in mammals. For example, leukocyte concentration remains constant regardless of body size in humans ([@bib5]). What drives organisms to have an optimal hemocyte/ blood cell concentration? In addition to their role in immunity, hemocytes have numerous other duties (*e.g.*, extracellular matrix deposition), and thus too many or too few hemocytes may result in both immunity and non-immunity related homeostatic imbalances ([@bib1]). For example, since hemocytes (and leukocytes more generally) are known to be high energy users, it may be metabolically detrimental to have too many hemocytes ([@bib7]). In support of this, a recent study showed that increases in hemocyte number cause sensitivity to nutrient deprivation ([@bib23]). Thus, the determinants of the optimal hemocyte concentration may be, at least in part, the result of competing energy needs between to roles of hemocytes and the growth of tissues.

Finally, we show that both [*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) and insulin-like signaling influence larval hemocyte numbers via their effect on larval growth. Tsl is produced by the prothoracic gland to promote growth, thus this is likely the source of Tsl for its role in the control of larval hemocyte expansion ([@bib11]). Tsl facilitates larval growth by promoting systemic insulin-like signaling and as such [*tsl*](https://identifiers.org/bioentitylink/FB:FBgn0003867?doi=10.1534/g3.120.401313) mutants likely have reduced hemocyte numbers due to reduced levels of insulin-like signaling. This is supported by our findings that reduced levels of insulin-like signaling results in a similar reduction in larval hemocyte number.

Insulin-like signaling plays an important role in the coordination of growth for many organs in response to changes in extrinsic factors such as nutrient availability ([@bib12]). In these organs, insulin-like signaling stimulates growth and proliferation via the activation of InR in target cells (reviewed in [@bib33]). We find that this mode of action holds true in hemocytes, as modulating InR activity in larval hemocytes results in concomitant changes in larval hemocyte number without affecting larval body size. This is perhaps unsurprising given that insulin-like signaling has previously been implicated in the control of embryonic hemocyte number ([@bib31]) and that the insulin-like peptides responsible for mediating a large proportion of InR-dependent growth are in circulation and therefore in direct contact with larval hemocytes ([@bib26]). Interestingly however, our data also revealed that hemocyte number and body size remain coordinated even when insulin-like signaling is compromised. This strongly suggests that additional growth pathways are likely to be involved in maintaining normal hemocyte concentrations. One recently identified factor that may play a role here is NimB5, which is secreted from fat body cells in a nutrient-dependent manner to dampen hemocyte proliferation and avoid energy wastage ([@bib23]). It will be interesting to learn how NimB5, insulin-like signaling and other pathways control hemocyte numbers with respect to *Drosophila* growth and determine the extent to which they are conserved across animals.
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